Analysis of plasmid DNA from a pharmaceutical perspective.
about
Characterization and performance of nucleic acid nanoparticles combined with protamine and gold.Non-viral peptide-based approaches to gene delivery.Real-time and quantitative PCR: applications to mechanism-based toxicology.Stabilization of pharmaceuticals to oxidative degradation.Growth factor delivery-based tissue engineering: general approaches and a review of recent developmentsHydrolysis in pharmaceutical formulations.Metal contaminants promote degradation of lipid/DNA complexes during lyophilization.Controlled release strategies for modulating immune responses to promote tissue regenerationMatrices and scaffolds for DNA delivery in tissue engineeringLayered PLG scaffolds for in vivo plasmid delivery.Plasmid DNA vaccine vector design: impact on efficacy, safety and upstream production.Solid lipid nanoparticles for applications in gene therapy: a review of the state of the art.Long-term structural changes of plasmid DNA studied by atomic force microscopy.Phase behavior of cationic amphiphiles and their mixtures with helper lipid influences lipoplex shape, DNA translocation, and transfection efficiency.Controlled release of plasmid DNA from biodegradable scaffolds fabricated using a thermally-induced phase-separation method.Formulation and in vitro transfection efficiency of poly (D, L-lactide-co-glycolide) microspheres containing plasmid DNA for gene deliveryEctoine can enhance structural changes in DNA in vitro.Preparation of DNA dry powder for non-viral gene delivery by spray-freeze drying: effect of protective agents (polyethyleneimine and sugars) on the stability of DNA.The effect of protective agents on the stability of plasmid DNA by the process of spray-drying.Amphiphilic triblock copolymer poly(p-dioxanone-co-L-lactide)-block-poly(ethylene glycol), enhancement of gene expression and inhibition of lung metastasis by aerosol delivery.Drug-releasing scaffolds fabricated from drug-loaded microspheres.
P2860
Q33499568-01F815EE-F35A-468C-AE6F-28225E91BCDAQ33842955-10EA7E65-174F-481F-BED5-493E0A2002F1Q34292412-DB6D2850-C5DC-4428-BFB1-DB098D736E21Q34536804-61561F88-B05B-4FDD-A831-4BF5948B04A4Q34548765-E2076745-B8B5-4C0D-BAA1-FB6068987AC0Q34687296-5093FB68-3DF9-4952-A1B6-A4ECEA245035Q35750255-1A81FFF3-04CF-428A-A699-B15B1F1C4D17Q36307642-9331BDB8-69FC-416B-A62B-43FE9EFAE726Q36826532-796DB088-2EB4-4E0F-80F1-D9CB8F097AF5Q37095858-3B53FBF6-E7DD-482A-BC06-ECA7BA4E2C57Q37398200-9DC54B9D-14A5-4A7A-8F7A-A8F50B59C7E0Q37657507-0CA01341-B69C-4EDC-B6AF-A9FD9E50A0E0Q39743933-3DBE0E75-76BE-4BBA-B68E-7D9CDEB8738EQ40215343-B0FD8D5A-482A-4A16-B62E-780752404515Q40471957-4E93C848-084E-4C1F-900B-B3A431ABFA6CQ40598735-AB021374-F1C6-4619-BDCA-413CAB7B23B2Q41242718-5FC07C5B-ACBD-4EFB-AFEA-68272F6144CCQ42831239-C0547365-78F6-4AE8-AD1B-5D51A680B6B7Q44424889-14AA3471-32C7-4D41-AFC6-07D5276EB9CEQ45863953-DD578F67-D1B1-4584-976D-D302CB4E87D2Q53881680-EC67FFC3-B70B-47C5-957C-F2501CA40706
P2860
Analysis of plasmid DNA from a pharmaceutical perspective.
description
1998 nî lūn-bûn
@nan
1998年の論文
@ja
1998年論文
@yue
1998年論文
@zh-hant
1998年論文
@zh-hk
1998年論文
@zh-mo
1998年論文
@zh-tw
1998年论文
@wuu
1998年论文
@zh
1998年论文
@zh-cn
name
Analysis of plasmid DNA from a pharmaceutical perspective.
@en
type
label
Analysis of plasmid DNA from a pharmaceutical perspective.
@en
prefLabel
Analysis of plasmid DNA from a pharmaceutical perspective.
@en
P2093
P356
P1476
Analysis of plasmid DNA from a pharmaceutical perspective.
@en
P2093
Casimiro DR
Middaugh CR
Montgomery DL
P304
P356
10.1021/JS970367A
P407
P577
1998-02-01T00:00:00Z